Media coverage
3
Media coverage
Title Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Media name/outlet Market News Publishing Country/Territory United States Date 3/06/24 Persons Joshua Brody Title Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma Media name/outlet BioSpace Country/Territory United States Date 2/06/24 URL ct.moreover.com/?a=53965945455&p=1gw&v=1&x=WuVmndUwCjtKts8OyvKHhA Persons Joshua Brody Title Genmab: Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma Media name/outlet India Pharma News Country/Territory India Date 2/06/24 Persons Joshua Brody